Tanja Krainz

Title: Tanja Krainz: Innovator in Cardiovascular Treatment

Introduction

Tanja Krainz is a notable inventor based in Cambridge, MA, who has made significant contributions to the field of cardiovascular medicine. Her innovative work focuses on the development of new therapeutic agents aimed at treating various cardiovascular diseases.

Latest Patents

Tanja holds a patent for "Substituted hydantoinamides as ADAMTS7 antagonists." This patent relates to substituted hydantoinamides of formula (I) that serve as ADAMTS7 antagonists. The application details processes for their preparation and their use, either alone or in combination, for the treatment or prophylaxis of diseases, particularly cardiovascular diseases such as atherosclerosis, coronary artery disease (CAD), peripheral vascular disease (PAD), arterial occlusive disease, or restenosis after angioplasty.

Career Highlights

Throughout her career, Tanja has worked with prominent organizations, including Bayer Aktiengesellschaft and The Broad Institute, Inc. Her experience in these institutions has allowed her to develop her expertise in the field of cardiovascular research and innovation.

Collaborations

Tanja has collaborated with various professionals in her field, including her coworker Yolanda Cancho Grande, who has also contributed to advancements in medical research.

Conclusion

Tanja Krainz is a pioneering inventor whose work in developing ADAMTS7 antagonists represents a significant advancement in the treatment of cardiovascular diseases. Her contributions continue to impact the medical field positively.